Silliker, Inc. (Homewood, IL) has received a grant to study the allicin bioavailability of garlic products, the company announced on November 24.
HOMEWOOD, IL-Silliker, Inc. has received a grant to study the allicin bioavailability of garlic products, the company announced on November 24.
Allicin is the main, active compound of garlic that is known to provide the most health benefits.
The $599,500 award was been granted by the National Institute of Health and the National Center for Complementary and Alternative Medicine (NIH/NCCAM; Bethesda, MD), and will cover a minimum two-year period.
Most garlic supplements have allicin levels of about 3-15 percent, compared to 100 percent in raw garlic. Without clinical research, however, it is difficult to make advancements in the field.
The conclusions of the study, Silliker stated, will address three main goals:
“1) An understanding of what type of supplements should be used in a clinical trial and in what form it should be consumed.
2) How results can be extrapolated to crushed raw garlic.
3) Provide supplement manufacturers with a correct standard for the design and evaluation of garlic supplements."
This is the third grant Silliker has received from NIH and NCCAM.
The Nutritional Outlook Podcast Episode 33: Keeping up with contract manufacturing
July 26th 2024Nutritional Outlook talks to Lauren Samot, commercial innovation leader, and Blayney McEneaney, sales executive at Vitaquest International, about trends within the contract manufacturing space, and the ways in which contract manufacturers like Vitaquest keep up with the market and differentiate themselves from the competition.